KUTRASE Rx

Select the drug indication to add to your list

KUTRASE

Digestive and biliary disorders
Only 4 drugs may be compared at once

Generic Name and Formulations:

Lipase 1200 Units, amylase 30000 Units, protease 30000 Units; caps.

Company:

UCB Inc.

Select therapeutic use:

Indications for KUTRASE:

Symptomatic treatment of digestive dysfunction.

Adult:

May be opened and sprinkled on food. 1 cap with meals or snacks.

Children:

Not recommended.

Contraindications:

Glaucoma. GI or urinary tract obstruction. Paralytic ileus. Intestinal atony. Unstable cardiovascular status. Severe ulcerative colitis. Toxic megacolon. Myasthenia gravis. Acute pancreatic conditions. Pork allergy.

Warnings/Precautions:

High environmental temperature. Diarrhea (may indicate obstruction). Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease (esp. tachycardia). CHF. Arrhythmias. Hypertension. Renal disease. Hiatal hernia associated with reflux esophagitis. Avoid inhaling contents of caps. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Avoid concomitant antacids.

Pharmacological Class:

Digestive enzymes.

Adverse Reactions:

Drowsiness, dizziness, blurred vision, other anticholinergic effects, suppression of lactation, paradoxical excitement, diarrhea.

How Supplied:

Caps—100